Drug Profile
Leuprorelin - Generex Biotechnology Corporation/NHTherapeutics
Alternative Names: NH 901Latest Information Update: 22 Feb 2023
Price :
$50
*
At a glance
- Originator Generex Biotechnology Corporation; NHTherapeutics
- Developer Generex Biotechnology Corporation
- Class Antineoplastics; Gonadotropins; Infertility therapies; Oligopeptides; Pituitary hormone releasing hormones
- Mechanism of Action Gonadotropin releasing hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypogonadism